一个史蒂文斯-约翰逊综合征病例用口服环素治疗
Victoria Griffith1, Amanda Ramnot2, Sydney R Resnik3
1Department of Graduate Medical Education, Memorial Healthcare, Pembroke Pines, FL, United States.
Journal of family medicine and primary care
|February 16, 2024
概括
史蒂文斯-约翰逊综合征 (SJS) 和有毒表皮解体 (TEN) 是严重的药物反应. 建议在早期接受环素治疗,特别是在儿童中,以阻止疾病的进展并改善结果.
科学领域:
- 皮肤病学 皮肤病学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 史蒂文斯-约翰逊综合征 (SJS) 和有毒表皮解体 (TEN) 是严重的粘膜皮肤药物不良反应.
- 这些情况需要迅速诊断和管理,包括药物戒断和适当的治疗.
- 儿童SJS/TEN诊断具有挑战性,因为症状与感染重叠.
研究的目的:
- 突出SJS/TEN在儿科患者的诊断挑战.
- 强调SJS/TEN早期干预的重要性.
- 建议使用环素作为SJS/TEN的潜在治疗方法,特别是在儿童中.
主要方法:
- 审查关于SJS/TEN诊断和治疗的现有文献.
- 临床观察和病例报告 (隐含).
- 对环素的机制和疗效的药理学审查.
主要成果:
- 环素在SJS/TEN患者中显示出有前途的治疗效果.
- 在SJS/TEN治疗的背景下,环素具有有利的副作用概况.
- 早期启动环素可以阻止疾病的进展.
结论:
- 迅速诊断和停止违规行为对SJS/TEN管理至关重要.
- 如果怀疑SJS/TEN,特别是在儿科病例中,建议进行循环氨酸修饰治疗,以加快疾病控制.
- 进一步的研究可能是有必要的,以建立最终的治疗方案.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
119
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
119
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
486
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
486
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K


